Yongjiang Yu
1665 Kongjiang Rd
Yangpu, 200092, China
Yangpu, 200092, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Targeting RPS6KC1 to overcome enzalutamide resistance in prostate cancer.
Journal: Biomarker research
Published: October 08, 2024
SLC4A4 is a novel driver of enzalutamide resistance in prostate cancer.
Journal: Cancer letters
Published: May 05, 2024
Evaluating the Role of Morphological Parameters in the Prostate Transition Zone in PHI-Based Predictive Models for Detecting Gray Zone Prostate Cancer.
Journal: Clinical Medicine Insights. Oncology
Published: April 14, 2023
Tumor-associated macrophages promote migration and invasion via modulating IL-6/STAT3 signaling in renal cell carcinoma.
Journal: International immunopharmacology
Published: May 12, 2022
The modified prostate health index (PHI) outperforms PHI density in the detection of clinical prostate cancer within the PSA grey zone.
Journal: International urology and nephrology
Published: December 19, 2021
Non-drug efflux function of ABCC5 promotes enzalutamide resistance in castration-resistant prostate cancer via upregulation of P65/AR-V7.
Journal: Cell death discovery
Published: October 18, 2021
Non-apoptotic function of caspase-8 confers prostate cancer enzalutamide resistance via NF-κB activation.
Journal: Cell death & disease
Published: February 08, 2021
Urinary neutrophil gelatinase-associated lipocalin as a biomarker to monitor renal function in patients with obstructive ureteral calculi.
Journal: World journal of urology
Published: August 21, 2018
Comparation of the predictive value between ultrasonography and urodynamics for the efficacy of transurethral resection of prostate in benign prostatic hyperplasia patients.
Journal: Chinese medical journal
Published: July 18, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026